DEFENT Fentanyl Test Kits by DDI Introduce Anonymous Reporting Tool to Combat Opioid Epidemic

LOS ANGELES - Oct. 8, 2024 - PRLog -- Defense Diagnostics, Inc. (DDI) introduces the DEFENT Fentanyl Test Kit, featuring the most sensitive test strips on the market and a first-of-its-kind anonymous reporting tool, strengthening community safety in the fight against the opioid crisis.

Key Features:

• Industry-first anonymous opt-in online reporting system for identifying fentanyl hot spots
• Most sensitive test strip on the market (15 ng/mL cut-off limit)
• Comprehensive kit includes 5 test strips, micro scoops, and a measuring cup
• Detects fentanyl and synthetic analogs like carfentanyl

The fentanyl epidemic claimed over 70,000 lives in 2023 and has cost the US economy over $1 trillion annually since 2018. DDI's DEFENT kit aims to make widespread testing accessible and commonplace, potentially saving countless lives by providing practical, user-friendly tools for consistent and accurate testing.

"We're proud to launch the DEFENT Fentanyl Test Kit, featuring our online reporting tool," said Ahmad Hussain, CEO of Defense Diagnostics. "This unique system allows users to anonymously report positive fentanyl test results, converting individual tests into valuable community-level insights. It significantly advances fentanyl detection, enabling users and public health officials to identify high-risk areas and make informed decisions."

The reporting tool allows users to scan a QR code on the packaging, inputting minimal information such as age range, tested substance, and location. This data is then aggregated and visualized on DDI's website, creating a real-time map of fentanyl presence across communities.

The DEFENT Fentanyl Test Kit is available through www.walmart.com and www.defent.com, with additional retail partnerships coming soon. DDI invites partners, stakeholders, and the wider community to join its efforts to improve how we test for and address critical societal problems.

About Defense Diagnostics Inc.:

Defense Diagnostics Inc. is a pioneering medical diagnostics company advancing fentanyl testing through innovative technology and a deep understanding of contemporary social realities. By combining high-quality science with user-friendly design, DDI creates accessible, practical detection tools to enhance public safety and promote proactive health management.